Gossamer Bio, Inc. (GOSS) Form SCHEDULE 13D/A — Sep 28, 2026
The D. E. Shaw group filed Amendment No. 4 to its Schedule 13D on Gossamer Bio, disclosing that Valence ceased to be a beneficial owner of more than 5% of GOSS common shares on September 24, 2026.
Key figures
- Shares Outstanding
- 6116391
- Sub 5pct date
- 2026-09-24
- Cogence percent
- 0.2%
- Valence percent
- 4.9%
- Reverse split ratio
- 1:80
- Cogence shares owned
- 15190
- Valence shares owned
- 296858
- Aggregate desco shares
- 312048
- Aggregate desco percent
- 5.1%
- Cogence open short positions
- 2290
- Valence open short positions
- 44364
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.